The Keck School of Medicine of the University of Southern California (USC) is one of four institutions to receive a multi-million dollar grant from the California Institute for Regenerative Medicine (CIRM) for translational research projects. The $2.5 million grant will support potential osteoarthritis therapies that could significantly impact standards of care for the disease. Arthritis affects approximately 52 million adults in the United States, with that number conservatively expected to grow to 78 million by the year 2040.

Grant recipient Denis Evseenko, associate professor of orthopaedic surgery, and stem cell biology and regenerative medicine, is working toward this therapy by using pluripotent stem cells to regenerate cartilage.

To read more, visit stemcell.usc.edu/2016/12/21/denis-evseenko-receives-2-5-million-from-california-institute-for-regenerative-medicine-cirm-for-osteoarthritis-research.